Home » Topics » Regulatory

Regulatory
RSS

A new surgically implantable haloperidol formulation for long-term treatment of schizophrenia

July 9, 2002

First market approval granted in Japan for Iressa

July 8, 2002

Potential new applications of topiramate discussed at the CINP congress

July 8, 2002

E.U. approval for Zenapax in pediatric renal transplantation

July 5, 2002

FDA approval for Remicade for remission maintenance of Crohn's disease

July 5, 2002

Buprenorphine matrix patch for chronic pain relief launched in U.K.

July 5, 2002

CPMP recommends approval of new indication for clopidogrel

July 3, 2002

Nonapprovable letter issued for Risperdal Consta

July 3, 2002

Nolvadex warnings strengthened

July 3, 2002

Atrix files IND for transmucosal sumatriptan

July 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...